| Recruiting | A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2026-02-11 |
| Recruiting | First-in-human Study of 7MW4911 in GI Cancer GI Cancers | Phase 1 / Phase 2 | 2026-01-13 |
| Recruiting | First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2025-11-12 |
| Recruiting | A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs Triple Negative Breast Cancer | Phase 1 | 2025-08-11 |
| Recruiting | 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer Urothelial Carcinoma | Phase 2 | 2025-08-01 |
| Recruiting | A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease COPD | Phase 2 | 2025-07-15 |
| Not Yet Recruiting | 9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors Gynecological Malignancies | Phase 1 / Phase 2 | 2025-04-15 |
| Not Yet Recruiting | A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2025-04-01 |
| Recruiting | 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent | Phase 2 | 2025-01-17 |
| Recruiting | A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia Beta-Thalassemia | Phase 1 | 2024-12-30 |
| Recruiting | A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis Postmenopausal Women Osteoporosis | Phase 3 | 2024-11-16 |
| Recruiting | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic C Cervical Cancer | Phase 3 | 2024-09-10 |
| Recruiting | 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Urothelial Carcinoma | Phase 3 | 2024-08-22 |
| Recruiting | A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Canc Triple-Negative Breast Cancer | Phase 2 | 2024-07-26 |
| Recruiting | A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients Polycythemia Vera | Phase 1 | 2024-03-21 |
| Recruiting | A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metast Advanced Urothelial Carcinoma | Phase 3 | 2023-12-29 |
| Recruiting | 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer Advanced Urothelial Carcinoma | Phase 1 / Phase 2 | 2023-09-27 |
| Unknown | A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-09-05 |
| Unknown | A Study of 7MW3711 in Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-08-28 |
| Active Not Recruiting | Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-08-28 |
| Unknown | A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Heal Idiopathic Pulmonary Fibrosis | Phase 1 | 2023-07-26 |
| Active Not Recruiting | Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW19 Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 / Phase 2 | 2023-07-06 |
| Unknown | A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 i Advanced Malignant Solid Tumor | Phase 1 | 2023-06-30 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects Pulmonary Fibrosis, Tumor | Phase 1 | 2023-03-20 |
| Completed | Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject Healthy | Phase 1 | 2023-03-10 |
| Unknown | 6MW3511 in Patients With Advanced Solid Tumor Solid Tumors | Phase 1 / Phase 2 | 2022-10-01 |
| Unknown | A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma Lymphoma | Phase 2 | 2022-09-01 |
| Unknown | A Clinical Study of 6MW3211 in Patients With Renal Cancer Advanced Clear Cell Renal Cell Carcinoma | Phase 2 | 2022-09-01 |
| Suspended | A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2022-08-05 |
| Unknown | A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer Advanced Lung Cancer | Phase 2 | 2022-07-10 |
| Unknown | A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 / Phase 2 | 2022-07-08 |
| Recruiting | A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors Advanced Malignant Solid Tumors | Phase 1 | 2022-06-21 |
| Unknown | A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2022-06-11 |
| Unknown | Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema Diabetic Macular Edema | Phase 3 | 2022-02-28 |
| Unknown | A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections Skin Infection | Phase 2 | 2022-02-16 |
| Completed | A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection Asthma, COPD, Atopic Dermatitis | Phase 1 | 2022-01-21 |
| Completed | An Evaluation of 9MW1911 Injection in Healthy Subjects Asthma, COPD, Atopic Dermatitis | Phase 1 | 2021-12-15 |
| Unknown | A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm Advanced Malignant Neoplasm | Phase 1 / Phase 2 | 2021-09-27 |
| Unknown | A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD Wet Age-related Macular Degeneration | Phase 2 / Phase 3 | 2021-05-07 |
| Completed | A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection Staphylococcus Aureus Infection | Phase 1 | 2021-04-16 |
| Completed | Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema Diabetic Macular Edema | Phase 1 | 2021-02-26 |
| Unknown | A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19 Covid19 | Phase 2 | 2020-12-29 |
| Completed | Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF Breast Cancer Female | Phase 2 / Phase 3 | 2020-09-21 |
| Unknown | Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2020-09-03 |
| Completed | A Clinical Study to Evaluate MW33 Injection Covid19 | Phase 1 | 2020-08-07 |
| Completed | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy A Osteoporosis, Postmenopausal | Phase 1 | 2020-06-02 |
| Completed | Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors Bone Metastases | Phase 3 | 2020-03-20 |
| Completed | Efficacy and Safety of MW031 in PMO Subjects Osteoporosis, Postmenopausal | Phase 3 | 2019-12-27 |
| Completed | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Ad Bone Tumor | Phase 1 | 2019-06-25 |